Suzzane Maahs
- Late-breaking abstract: Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting the allergen-induced early asthmatic responseBy Gail M. Gauvreau, Louis-Philippe Boulet, Richard Leigh, Donald W. Cockcroft, Beth E. Davis, Irvin Mayers, J Mark FitzGerald, Barbro Dahlen, Richard M. Watson, Joanne Milot, Veronica Swystun, Linda Hui, Ann-Sofie Lantz, Miranda Bowen, Jonathan Arm, Suzzane Maahs, Karin Meiser, Philip Lowe, Andrej Skerjanec, Christopher Carlsten, Karin Strandberg, Kieran J. Killian, Michele Laviolette, Anton Drollmann and Paul M. O'ByrneGail M. Gauvreau1Department of Medicine, McMaster University, Hamilton, ON, CanadaLouis-Philippe Boulet2Department of Medicine, Université Laval, Québec, QC, CanadaRichard Leigh3Medicine and Physiology and Pharmacology, University of Calgary, Calgary, AB, CanadaDonald W. Cockcroft4Department of Medicine, University of Saskatchewan, Royal University Hospital, Saskatoon, SK, CanadaBeth E. Davis4Department of Medicine, University of Saskatchewan, Royal University Hospital, Saskatoon, SK, CanadaIrvin Mayers5Department of Medicine, University of Alberta, Edmonton, AB, CanadaJ Mark FitzGerald6Department of Medicine, University of British Columbia, Vancouver, BC, CanadaBarbro Dahlen7Karolinska Institutet (KI), Department of Medicine, Karolinska University, Stockholm, SwedenRichard M. Watson1Department of Medicine, McMaster University, Hamilton, ON, CanadaJoanne Milot2Department of Medicine, Université Laval, Québec, QC, CanadaVeronica Swystun3Medicine and Physiology and Pharmacology, University of Calgary, Calgary, AB, CanadaLinda Hui6Department of Medicine, University of British Columbia, Vancouver, BC, CanadaAnn-Sofie Lantz7Karolinska Institutet (KI), Department of Medicine, Karolinska University, Stockholm, SwedenMiranda Bowen5Department of Medicine, University of Alberta, Edmonton, AB, CanadaJonathan Arm8Novartis Institutes for Biomedical Research, Novartis, Basel, SwitzerlandSuzzane Maahs9Novartis Institutes for Biomedical Research, Novartis, East Hanover, NJ,Karin Meiser10Integrated Information Sciences, Novartis Pharma AG, Basel, SwitzerlandPhilip Lowe10Integrated Information Sciences, Novartis Pharma AG, Basel, SwitzerlandAndrej Skerjanec8Novartis Institutes for Biomedical Research, Novartis, Basel, SwitzerlandChristopher Carlsten6Department of Medicine, University of British Columbia, Vancouver, BC, CanadaKarin Strandberg7Karolinska Institutet (KI), Department of Medicine, Karolinska University, Stockholm, SwedenKieran J. Killian1Department of Medicine, McMaster University, Hamilton, ON, CanadaMichele Laviolette2Department of Medicine, Université Laval, Québec, QC, CanadaAnton Drollmann8Novartis Institutes for Biomedical Research, Novartis, Basel, SwitzerlandPaul M. O'Byrne1Department of Medicine, McMaster University, Hamilton, ON, Canada
- QGE031 (ligelizumab) is more effective than omalizumab and placebo in inhibiting allergen-induced early asthmatic response: Results from a predictive modeling studyBy Gail M. Gauvreau, Louis-Philippe Boulet, Richard Leigh, Donald W. Cockcroft, Beth E. Davis, Irvin Mayers, J. Mark FitzGerald, Barbro Dahlen, R.M. Watson, Joanne Milot, Veronica Swystun, Linda Hui, Ann-Sofie Lantz, Miranda Bowen, Jonathan Arm, Suzzane Maahs, Karin Meiser, Philip Lowe, Andrej Skerjanec, Christopher Carlsten, Karin Strandberg, Kieran J. Killian, Michele Laviolette, Anton Drollmann and Paul M. O'ByrneGail M. Gauvreau1Cardio-Respiratory Lab, McMaster University, Hamilton, ON CanadaLouis-Philippe Boulet2Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, QC CanadaRichard Leigh3Faculty of Medicine, University of Calgary, Caldary, AB CanadaDonald W. Cockcroft4Respirology, Critical Care and Sleep Medicine, University of Saskatchewan, Saskatoon, SK CanadaBeth E. Davis4Respirology, Critical Care and Sleep Medicine, University of Saskatchewan, Saskatoon, SK CanadaIrvin Mayers5Department of Medicine, University of Alberta, Edmonton, AB CanadaJ. Mark FitzGerald6Respiratory Medicine, University of British Columbia, Vancouver, BC CanadaBarbro Dahlen7Unit of Heart and Lung Diseases, Karolinska University, Stockholm, SwedenR.M. Watson1Cardio-Respiratory Lab, McMaster University, Hamilton, ON CanadaJoanne Milot2Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, QC CanadaVeronica Swystun3Faculty of Medicine, University of Calgary, Caldary, AB CanadaLinda Hui6Respiratory Medicine, University of British Columbia, Vancouver, BC CanadaAnn-Sofie Lantz7Unit of Heart and Lung Diseases, Karolinska University, Stockholm, SwedenMiranda Bowen5Department of Medicine, University of Alberta, Edmonton, AB CanadaJonathan Arm8Novartis Institutes for Biomedical Research, Basel, SwitzerlandSuzzane Maahs9Novartis Institutes for Biomedical Research, East Hanover, NJ United StatesKarin Meiser10Novartis Pharma AG, Basel, SwitzerlandPhilip Lowe10Novartis Pharma AG, Basel, SwitzerlandAndrej Skerjanec10Novartis Pharma AG, Basel, SwitzerlandChristopher Carlsten6Respiratory Medicine, University of British Columbia, Vancouver, BC CanadaKarin Strandberg7Unit of Heart and Lung Diseases, Karolinska University, Stockholm, SwedenKieran J. Killian1Cardio-Respiratory Lab, McMaster University, Hamilton, ON CanadaMichele Laviolette2Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, QC CanadaAnton Drollmann8Novartis Institutes for Biomedical Research, Basel, SwitzerlandPaul M. O'Byrne1Cardio-Respiratory Lab, McMaster University, Hamilton, ON Canada
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
